Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive rosuvastatin after PPCI in older STEMI patients
ChiCTR2200066956Phase 3Recruiting
- Sponsor
- Zhongshan Hospital Affiliated to Fudan University Qingpu Branch
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rosuvastatin in myocardial infarction (MI) (2 arms), sponsored by Zhongshan Hospital Affiliated to Fudan University Qingpu Branch. Primary endpoint: blood lipid. Started Jan 2022; status: recruiting.
02
Drugs
rosuvastatin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2200066956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066956.